Company profile: Nelson Labs
1.1 - Company Overview
Company description
- Provider of microbiological testing and consulting services for MedTech companies, offering analytical lab testing, method development and validation, stability studies, extractables and leachables testing, and support for regulatory submissions, product development, and quality assurance to ensure product safety, efficacy, and compliance.
Products and services
- Consulting Services: Offers regulatory-focused expertise supporting regulatory submissions, product development, and quality assurance for MedTech companies, aligning strategies to minimize client risk and improve patient outcomes
- Method Development and Validation: Produces validated test methods to ensure accurate and reliable results, architecting assays that underpin product development decisions and regulatory submissions
- Microbiological Testing: Delivers industry-standard assays to ensure product safety and efficacy by identifying and quantifying microorganisms for MedTech companies, minimizing client risk and improving patient outcomes
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nelson Labs
Pharmalog
HQ: Germany
Website
- Description: Provider of clinical research services as a clinical research organization, conducting Phase I and Phase II–IV trials for pharmaceutical and biotechnology companies, as well as non-interventional (NIS) studies. Offers research programs, special trials including dermatological/cosmetic studies, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmalog company profile →
ApoCell
HQ: United States
Website
- Description: Provider of clinical trial, laboratory, and data science services as a clinical research organization, with biomarker development and diagnostics capabilities, supporting diabetes, molecular diagnostics, drug development, oncology, orphan diseases, gene therapy, and neuroscience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ApoCell company profile →
Chemoxy
HQ: United Kingdom
Website
- Description: Provider of independent contract manufacturing services, supplying quality materials to countless industries. One of Europe’s largest independent contract manufacturers, with strong health and safety standards and operational structures supporting consistent quality.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Chemoxy company profile →
Cellca
HQ: Germany
Website
- Description: Provider of upstream technologies and services for mammalian protein manufacturing, including a proprietary CHO expression platform, rapid cell line development (DNA to research cell bank in ~14 weeks), cGMP cell banking, cell line and product characterization, and cGMP lot release testing aligned with ICH and USP guidelines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellca company profile →
Cenexi
HQ: France
Website
- Description: Provider of sterile pharmaceutical manufacturing and CDMO services, covering drug development, production, and regulatory support. Delivers formulation, analytical development, industrial transfer, and regulatory affairs. Produces prefilled syringes, liquid and lyophilized vials, and ampoules, including high potent and biological products; up to 37m syringes, 68m vials, and 410m ampoules annually.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cenexi company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nelson Labs
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nelson Labs
2.2 - Growth funds investing in similar companies to Nelson Labs
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nelson Labs
4.2 - Public trading comparable groups for Nelson Labs
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →